![Paul Mann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Mann
Directeur Général chez
ASP ISOTOPES INC.
Fortune : 60 M $ au 30/06/2026
Profil
Paul E.
Mann is the founder of ASP Isotopes, Inc., founded in 2021, serving as Executive Chairman & Chief Executive Officer.
Mr. Mann is the founder of Quantum Leap Energy LLC, founded in 2023, serving as Chairman.
Mr. Mann was also the founder of Varian Biopharma, Inc...
Current positions included President, CEO, CFO & Director at Aeternum Health, Inc. since 2026; Chairman at Healthtech Solutions, Inc. since 2021; Executive Chairman at Skyline Builders Group Holding Ltd. since 2026; and Independent Director at Illumination Acquisition Corp.
I since 2026.
Former positions include Chairman at Varian Biopharmaceuticals, Inc. from 2020 to 2023; Independent Non-Executive Director at Abeona Therapeutics, Inc. from 2020 to 2023; Chief Financial Officer at RegenETP, Inc. from 2018 to 2020; Executive Director at Morgan Stanley & Co. LLC in 2011; Research Analyst at UBS Ltd. (Broker) from 2011 to 2012; Research Analyst at UBS AG (Private Banking UK) from 2011 to 2012; Analyst at Althea Capital LLP from 2012 to 2013; Analyst at SFM UK Management LLP from 2013 to 2014; Analyst at Deutsche Bank AG (Broker UK) in 2007; Research Analyst at Morgan Stanley & Co. International Plc; Manager at Aeternum Health LLC; Manager-Healthcare Portfolio at Highbridge Capital Management LLC; Analyst at Soros Fund Management LLC; and Research Scientist at Procter & Gamble Co. Education includes undergraduate and graduate degrees from the University of Cambridge.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ASP ISOTOPES, INC. 7,61% | 03/06/2026 | 9 579 845 ( 7,61% ) | 60 M $ | 30/06/2026 |
Dernières actualités sur Paul Mann
Postes actifs de Paul Mann
| Sociétés | Poste | Début |
|---|---|---|
| HYB HOLDING CORP. | Président | 21/09/2021 |
| ASP ISOTOPES INC. | Directeur Général | 19/01/2026 |
Anciens postes connus de Paul Mann
| Sociétés | Poste | Fin |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/01/2023 |
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Président | 01/01/2023 |
| REGENETP, INC. | Directeur Financier/CFO | 01/04/2020 |
SFM UK Management LLP
 SFM UK Management LLP Investment ManagersFinance SFM UK is an active manager which invests based on analyzing global macroeconomic trends. The firm undertakes private investments in public equity and invests in currencies and index-linked derivatives. | Analyst-Equity | 01/07/2014 |
Althea Capital LLP
 Althea Capital LLP Investment ManagersFinance Provides investment advice | Analyst-Equity | 28/03/2013 |
Formation de Paul Mann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Procter & Gamble Co.
 Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Soros Fund Management LLC
 Soros Fund Management LLC Investment ManagersFinance SFM aims to protect and grow Open Society’s resources. The firm invests globally in a wide range of strategies and asset classes, including public equities, fixed income, commodities, foreign exchange, alternative assets and private equity. | Finance |
Highbridge Capital Management LLC
 Highbridge Capital Management LLC Investment ManagersFinance Highbridge seeks to generate attractive risk-adjusted returns by offering credit and volatility-focused solutions across a range of liquidity and investment profiles, including hedge funds, drawdown vehicles and co-investments. The firm opportunistically invests across the capital structure in less efficient segments of the market with the goal of generating consistent, alpha-driven returns across market cycles. | Finance |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
RegenETP, Inc.
 RegenETP, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes regenerative tissue products & biomaterials | Health Technology |
UBS Ltd. (Broker)
 UBS Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deutsche Bank AG (Broker UK)
 Deutsche Bank AG (Broker UK) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Morgan Stanley & Co. International Plc
 Morgan Stanley & Co. International Plc Investment Banks/BrokersFinance Provides brokerage services | Finance |
Healthtech Solutions, Inc.
 Healthtech Solutions, Inc. Packaged SoftwareTechnology Services Operates as a holding company whose subsidiaries develops artificial intelligence based image analysis software, ultrasound imaging, diagnostic laboratory and human cell & tissue products | Technology Services |
Althea Capital LLP
Althea Capital LLP Investment ManagersFinance Provides investment advice | Finance |
SFM UK Management LLP
SFM UK Management LLP Investment ManagersFinance SFM UK is an active manager which invests based on analyzing global macroeconomic trends. The firm undertakes private investments in public equity and invests in currencies and index-linked derivatives. | Finance |
UBS AG (Private Banking UK)
 UBS AG (Private Banking UK) Investment ManagersFinance UBS AG is an active manager which offers investment capabilities and styles across traditional and alternative asset classes. The firm provides clients with expert advice, innovative solutions, execution and comprehensive access to international capital markets. | Finance |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of cancer | Health Technology |
ASP Isotopes, Inc.
 ASP Isotopes, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-commercial stage materials company that produces, distributes, markets and sells isotopes | Health Technology |
Choisissez Zonebourse 
